Olympic Protein Technologies
Private Company
Funding information not available
Overview
Olympic Protein Technologies is a private, revenue-generating contract research organization providing end-to-end protein science services to biotechnology and pharmaceutical clients. The company's core competency lies in overcoming challenges in protein expression and purification, supported by a leadership team with deep industrial experience from companies like Amgen and Exelixis. Operating from a lab in Seattle, OPT offers a personalized, full-service model from construct design through biophysical characterization, positioning itself as a specialized partner for reagent and therapeutic candidate development. While not developing its own therapeutics, its services are critical enablers for clients' pipelines across multiple therapeutic areas.
Technology Platform
Integrated workflow for recombinant protein production featuring DNA sequence optimization, multi-system expression (E. coli, insect, mammalian cells), protein purification & modification, and characterization via biophysical analysis (e.g., SPR).
Opportunities
Risk Factors
Competitive Landscape
OPT competes in the fragmented protein services CRO market. It differentiates through deep industrial experience, a personalized service model, and a focus on solving challenging expression/purification problems. Key competitors range from large players like Charles River Laboratories, Lonza, and Thermo Fisher to smaller specialty labs like Absolute Antibody, ProteoGenix, and numerous academic core facilities.